Huazhong University Of Science And Technology
Clinical trials sponsored by Huazhong University Of Science And Technology, explained in plain language.
-
New drug shows promise for stuffy nose syndrome
Disease control Not yet recruitingThis study tests if the drug Stapokibart (CM310) can relieve symptoms of Non-Allergic Rhinitis with Eosinophilia Syndrome (NARES), a chronic nasal condition. About 90 adults will receive either the drug or a placebo every two weeks for 12 weeks. Researchers will track symptom cha…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 05:04 UTC
-
AI coach vs. weight-loss shot: which helps keep pounds off longer in diabetes?
Disease control Not yet recruitingThis study tests whether an AI-guided lifestyle program or continuing the drug tirzepatide is better at helping adults with type 2 diabetes and overweight maintain weight loss. All 400 participants first take tirzepatide for 20 weeks, then those who lose enough weight are randoml…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 04:36 UTC
-
New hope for stomach cancer: triple therapy shows promise
Disease control Not yet recruitingThis study tests a new treatment for people with advanced stomach cancer that has not spread to other parts of the body or has spread a little. The treatment combines two immunotherapy drugs, chemotherapy, and targeted radiation. The goal is to see if this combination can shrink …
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 26, 2026 04:35 UTC
-
New hope for advanced colon cancer: drug cocktail plus radiation tested
Disease control Not yet recruitingThis study is for people with metastatic colorectal cancer that has spread to a few spots (like the liver or lungs) and hasn't responded to at least two prior treatments. It tests whether adding two immunotherapy drugs (iparomlimab and tuvonralimab) plus targeted radiation to the…
Phase: PHASE2 • Sponsor: Huazhong University of Science and Technology • Aim: Disease control
Last updated May 18, 2026 11:59 UTC
-
Acupuncture needles may boost IVF success in stubborn infertility cases
Symptom relief Not yet recruitingThis study tests whether acupuncture can increase pregnancy rates in women who have had two or more failed embryo transfers. Researchers will compare pregnancy outcomes between those receiving acupuncture and those who do not. The trial involves 208 women aged 20-40 who are plann…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 26, 2026 05:10 UTC
-
New painkiller may cut opioid use after shoulder surgery
Symptom relief Not yet recruitingThis study tests if a long-acting version of a common painkiller works better than the standard version for pain after shoulder surgery. About 60 adults having arthroscopic shoulder surgery will receive one of the two medicines as a nerve block. The goal is to see if the long-act…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 26, 2026 05:06 UTC
-
Can a gentle brain zap ease stubborn shingles pain?
Symptom relief Not yet recruitingThis study tests a non-invasive brain stimulation technique to reduce pain in people with postherpetic neuralgia, a chronic nerve pain condition that can follow shingles. About 94 adults with moderate to severe pain will receive either real or sham (fake) stimulation to see if it…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 26, 2026 04:35 UTC
-
Can tiny needles cure menopausal insomnia? new trial aims to find out
Symptom relief Not yet recruitingThis study tests if a special type of acupuncture, using tiny thumbtack needles, can help women going through menopause sleep better. 198 women with chronic insomnia will either get real or fake needles for 4 weeks. The goal is to see if this simple treatment can ease their sleep…
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
New painkiller may cut opioid use after abdominal surgery
Symptom relief Not yet recruitingThis study tests if a long-acting form of the painkiller bupivacaine (called liposomal bupivacaine) can reduce the need for opioid pain medicine after laparoscopic liver, gallbladder, or pancreas surgery. About 60 adults will receive either the long-acting painkiller plus regular…
Phase: PHASE4 • Sponsor: Huazhong University of Science and Technology • Aim: Symptom relief
Last updated May 20, 2026 11:57 UTC
-
Can we predict dangerous side effects of immunotherapy? new study aims to find out
Knowledge-focused Not yet recruitingThis study will look for biological markers (biomarkers) that can predict serious side effects from immune checkpoint inhibitor therapy, a common cancer treatment. Researchers will follow 440 adults starting this therapy to build a model that forecasts who is at risk. The goal is…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 26, 2026 05:12 UTC
-
New study aims to catch pancreatic cancer recurrence early
Knowledge-focused Not yet recruitingThis study looks at whether tumor cells found in the portal vein (a major liver blood vessel) can warn early if pancreatic cancer comes back or spreads. Researchers will test 20 people with removable or borderline-removable pancreatic cancer. The goal is to improve monitoring and…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 20, 2026 11:55 UTC
-
AI tool design could make or break doctor trust, study finds
Knowledge-focused Not yet recruitingThis study looks at how different features of an AI system that helps doctors make decisions affect whether they actually use it. Researchers will have 3,000 primary care doctors in China test 32 different versions of an AI tool for diagnosing respiratory infections. The goal is …
Phase: NA • Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 19, 2026 11:48 UTC
-
Million-Person study to unlock secrets of chinese medicine for modern diseases
Knowledge-focused Not yet recruitingThis study will follow one million adults aged 30-74 in Hubei, China, for up to 10 years. Researchers will collect health data and Traditional Chinese Medicine (TCM) body types to see how they relate to chronic diseases like heart disease, cancer, and diabetes. The goal is to cre…
Sponsor: Huazhong University of Science and Technology • Aim: Knowledge-focused
Last updated May 11, 2026 20:48 UTC